Surface-Functionalized Model Contact Lenses with a Bioinspired Proteoglycan 4 (PRG4)-Grafted Layer
Source abstract
Abstract
Ocular dryness and discomfort are the primary reasons for the discontinuation of contact lens wear. This is mainly due to poorly hydrated contact lens surfaces and increased friction, particularly at the end of the day and can potentially cause reduced vision or even inflammation. Proteoglycan 4 (PRG4) is a mucinous glycoprotein with boundary lubricating properties, naturally found in the eye, able to prevent tear film evaporation and protect the ocular surface during blinking. Aiming to improve the interfacial interactions between the ocular surface and the contact lens, the synthesis and characterization of surface-modified model contact lenses with PRG4 is described. Full-length recombinant human PRG4 (rhPRG4) was successfully grafted onto the surface of model conventional and silicone hydrogel (SiHy) contact lenses via its somatomedin B-like end-domain using N,N′-carbonyldiimidazole linking chemistry. Grafting was assessed by Fourier transform infrared spectroscopy-attenuated total reflectance, X-ray photoelectron spectroscopy, and radioactive (I131) labeling. Surface immobilization of rhPRG4 led to model conventional and SiHy materials with improved antifouling properties, without impacting optical transparency or causing any toxic effects to human corneal epithelial cells in vitro. The surface wettability and the boundary friction against human corneal tissue were found to be substrate-dependent, with only the rhPRG4-grafted model SiHy exhibiting a reduced contact angle and kinetic friction coefficient compared to the unmodified surfaces. Hence, clinical grade rhPRG4 can be an attractive candidate for the development of novel bioinspired SiHy contact lenses, providing improved comfort and overall lens performance.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Ocular Surface and Contact Lens · Polymer Surface Interaction Studies · Adhesion, Friction, and Surface Interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical Engineering, McMaster University, Hamilton, Ontario L8S 4L7, Canada
Biomedical Engineering Graduate Program, University of Calgary, Calgary, Alberta T2N 1N4, Canada
Funding
Canada Research Chairs · Government of Canada
References (68)
Show source-provided references
1. Jones L. · Contact Lens Spectrum · 2002 · 17 · 24
2. Maldonado-Codina C. · 2010 · 67
3. 10.1016/s0142-9612(01)00165-x10.1016/s0142-9612(01)00165-x ↗
4. 10.1097/ICL.0b013e31827d546e10.1097/ICL.0b013e31827d546e ↗
5. 10.1167/iovs.05-139210.1167/iovs.05-1392 ↗
6. 10.1097/ICL.0b013e318271caf410.1097/ICL.0b013e318271caf4 ↗
7. 10.1097/01.ico.0000248382.32143.8610.1097/01.ico.0000248382.32143.86 ↗
8. 10.1167/iovs.13-1323510.1167/iovs.13-13235 ↗
9. 10.1167/iovs.13-1318710.1167/iovs.13-13187 ↗
10. Tomlinson A. · 1992 · 195
11. 10.1167/iovs.13-1321510.1167/iovs.13-13215 ↗
12. 10.1097/01.ICL.0000029344.37847.5A10.1097/01.ICL.0000029344.37847.5A ↗
13. 10.1097/OPX.0b013e318188890910.1097/OPX.0b013e3181888909 ↗
14. Brennan N. · Optom. Vis. Sci. · 2009 · 86 · E-abstract 9095
15. Coles C. · Optom. Vis. Sci. · 2012 · 89 · E-abstract 1256
16. 10.1016/j.clae.2013.08.04010.1016/j.clae.2013.08.040 ↗
17. 10.1529/biophysj.106.08879910.1529/biophysj.106.088799 ↗
18. 10.1023/A:102115961937310.1023/A:1021159619373 ↗
19. Jay G. D. · 1990
20. 10.1097/ACI.0b013e32830e6b0410.1097/ACI.0b013e32830e6b04 ↗
21. 10.1001/jamaophthalmol.2013.238510.1001/jamaophthalmol.2013.2385 ↗
22. Cheriyan T. · Mol. Vision · 2011 · 17 · 3055
23. 10.1016/j.jtos.2016.08.00410.1016/j.jtos.2016.08.004 ↗
24. 10.1097/ICL.0b013e31823f704110.1097/ICL.0b013e31823f7041 ↗
25. 10.1016/j.exer.2014.06.01510.1016/j.exer.2014.06.015 ↗
26. Schmidt T. A. · Invest. Ophthalmol. Visual Sci. · 2014 · 55 · 4651
27. 10.1016/j.triboint.2014.11.02210.1016/j.triboint.2014.11.022 ↗
28. 10.1021/la702383n10.1021/la702383n ↗
29. 10.1021/la702366t10.1021/la702366t ↗
30. 10.1002/jbm.a.1006010.1002/jbm.a.10060 ↗
31. 10.1039/c0ib00155d10.1039/c0ib00155d ↗
32. 10.1002/app.3453210.1002/app.34532 ↗
33. 10.1038/srep1891010.1038/srep18910 ↗
34. Regoeczi E. · 1984 · 17
35. 10.1163/092050611X56906010.1163/092050611X569060 ↗
36. 10.1002/jbm.b.3389510.1002/jbm.b.33895 ↗
37. 10.1002/jbm.b.3398910.1002/jbm.b.33989 ↗
38. 10.1007/s10856-010-4094-510.1007/s10856-010-4094-5 ↗
39. 10.1021/ac060881d10.1021/ac060881d ↗
40. 10.1016/j.actbio.2011.02.00110.1016/j.actbio.2011.02.001 ↗
41. 10.1021/la800786s10.1021/la800786s ↗
42. 10.1002/jbm.a.3221410.1002/jbm.a.32214 ↗
43. 10.3144/expresspolymlett.2014.510.3144/expresspolymlett.2014.5 ↗
44. 10.1016/s0076-6879(84)04083-010.1016/s0076-6879(84)04083-0 ↗
45. 10.1016/j.reactfunctpolym.2015.09.00410.1016/j.reactfunctpolym.2015.09.004 ↗
46. 10.1016/0021-9673(86)80090-510.1016/0021-9673(86)80090-5 ↗
47. 10.1016/j.biomaterials.2015.02.08610.1016/j.biomaterials.2015.02.086 ↗
48. Tighe B. · 2004 · 1
49. Zhao Z. · Mol. Vision · 2008 · 14 · 2016
50. 10.1016/j.polymer.2010.08.02210.1016/j.polymer.2010.08.022 ↗
51. 10.1007/s00424-007-0212-810.1007/s00424-007-0212-8 ↗
52. 10.1021/ja404681x10.1021/ja404681x ↗
53. 10.1021/la050988g10.1021/la050988g ↗
54. 10.1042/bj181071710.1042/bj1810717 ↗
55. Kern J. · Invest. Ophthalmol. Visual Sci. · 2013 · 54 · 49410.1167/iovs.12-10528 ↗
56. 10.1007/s11538-007-9252-710.1007/s11538-007-9252-7 ↗
57. 10.1007/s11249-012-0076-810.1007/s11249-012-0076-8 ↗
58. 10.1097/00140068-200301001-0001110.1097/00140068-200301001-00011 ↗
59. 10.1039/b907155e10.1039/b907155e ↗
60. 10.1016/j.actbio.2010.03.02510.1016/j.actbio.2010.03.025 ↗
61. 10.1016/j.joca.2012.09.01610.1016/j.joca.2012.09.016 ↗
62. 10.1243/13506501JET14310.1243/13506501JET143 ↗
63. Schaefer D. B. · Biorheology · 2004 · 41 · 503
64. 10.1097/ICL.0b013e318275452b10.1097/ICL.0b013e318275452b ↗
65. Offord E. A. · Invest. Ophthalmol. Visual Sci. · 1999 · 40 · 1091
66. 10.1016/j.ijpharm.2017.04.02410.1016/j.ijpharm.2017.04.024 ↗
67. 10.1002/jbm.a.3139110.1002/jbm.a.31391 ↗
68. 10.1016/j.ijpharm.2009.12.03310.1016/j.ijpharm.2009.12.033 ↗